related documents
- Advanced Prostate Imaging of Recurrent Cancer after Radiation Therapy (PICs): Interim Results of a Prospective, Multi-Center Trial Conferences
- Can the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Predict Survival or Local Control in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC)? A Systematic Review Conferences
- Comparison of the Clinical Behaviour of N3 HPV Related and Unrelated Head and Neck Cancer in the IMRT Era Conferences
- Development of Best Practices of Peer Review in Lung Radiation Therapy Conferences
- Does Modern Mediastinal Irradiation Cause Acute Subclinical Cardiac Toxicity? The Final Results of the MEDICATE Study (Mediastinal Irradiation and Cardio-Toxic Effects) Conferences
- Identifying Potential Predictors of Late Renal Toxicity after Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Prospective Cohort Study Conferences
- Lung SBRT Credentialing in the Canadian LUSTRE Randomized Trial Conferences
- Lymph Node Ratio as a Predictor of Distant Metastases in Major Salivary Gland Carcinomas Conferences
- Outcomes of Stereotactic Body Radiation Therapy for Abdominopelvic Oligometastases Conferences
- Outcomes of Tri-Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer Conferences
- Patient-Reported Quality of Life Following Stereotactic Body Radiation Therapy for Primary Kidney Cancer: Results from a Prospective Cohort Study Conferences
- Renal SABR in Patients with a Solitary Kidney: An Individual-Patient Pooled Analysis from the International Radiosurgery Oncology Consortium for Kidney (IROCK) Conferences
- Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial Conferences
- Systematic Review of the Incidence of Chest Wall Toxicity Following Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer Conferences
- Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials Conferences